Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 10, No. 4
April 2004

Adobe Acrobat logo

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

PDF Version | Comments Comments | Email this article Email this article



The Study
Conclusions
References
Figure 1
Figure 2
Table 1
Table 2

This page was updated on June 9, 2004 to incorporate the corrections in Vol. 10, No. 7

Dispatch

Murine Typhus with Renal Involvement in Canary Islands, Spain

Michele Hernández-Cabrera,1*† Alfonso Angel-Moreno,1*† Evora Santana,*† Margarita Bolaños,* Adela Francès,* Antonio-Manuel Martín-Sánchez,*† and Jose Luis Pérez-Arellano*†Comments
*Hospital Universitario Insular de Gran Canaria, Canary Islands, Spain; and †Universidad de Las Palmas de Gran Canaria, Canary Islands, Spain

Suggested citation for this article: Hernández-Cabrera M, Angel-Moreno A, Santana E, Bolaños M, Francès A, Martín-Sánchez A-M, et al. Murine typhus with renal involvement in Canary Islands, Spain. Emerg Infect Dis [serial online] 2004 Apr [date cited]. Available from: http://www.cdc.gov/ncidod/EID/vol10no4/03-0532.htm


Murine typhus and "murine-thypus-like" disease are reemerging infectious diseases. In Canary Islands (Spain), a rather distinct clinical pattern characterized by higher incidence of complications, especially renal damage (including acute failure and urinalysis abnormalities), is apparent and highly suggestive. It could be related to different strains of Rickettsia typhi or other cross-reactive species.

The Study

Murine or endemic typhus is caused by Rickettsia typhi, formerly R. mooseri (1). Classic murine typhus is a zoonosis maintained in rats (Rattus rattus and Rattus norvergicus) and transmitted to humans through damaged skin by infected feces from the oriental rat flea (Xenopsylla cheopis) (2). New patterns of disease ("murine typhus-like" disease) have been described in recent years, and a new species of Rickettsia (R. felis) that causes a similar clinical picture has been identified (1–3). New modes of infection have been identified, including infection through inhalation of flea feces and transmission by different types of fleas (Ctenophtephalis felis) and from different reservoirs (e.g., dog, cat, and opossum).

Murine typhus occurs worldwide, particularly in warm and humid climates (1). In Spain, two seroepidemiologic surveys, in Salamanca and Madrid (Central/Western Spain), yielded seroprevalence rates of 12.8% and 6.8%, respectively, in the general population (4,5). However, no clinical cases have been reported. In Seville (Southwestern Spain), murine typhus is an important cause of fever of intermediate duration (6), and in Canary Islands, 10 autochthonous cases have been reported from Tenerife (7). For this reason, we include serologic testing for R. typhi in the evaluation of patients with fever of intermediate duration. We describe the clinical picture of murine typhus in the Canary Islands.

Adult (>14 years of age) inpatients and outpatients at the Hospital Universitario Insular of Las Palmas with a serologic diagnosis of murine typhus during December 1, 2000, through July 30, 2002, were included in our study. A case was defined by an immunoglobulin (Ig) M titer >1: 40, or a fourfold or higher increase in IgG titers against R. typhi by direct immunofluorescence test in 8 weeks (bioMeriéux, France), or both.

Figure 1
Figure 1.

Click to view enlarged image

Figure 1. Distribution of cases of murine typhus by season.

  

Figure 2

Figure 2.
Click to view enlarged image

Figure 2. Distribution of cases of murine typhus by geographic area.

Epidemiologic, clinical, and laboratory data were collected. Antibodies against other agents that may cause a fever of intermediate duration (e.g., Coxiella burnetii, R. conorii, Leptospira sp., Epstein-Barr virus, and cytomegalovirus) were systematically tested. Twenty-two patients (21 men, 1 woman), with a mean age of 28 years (range 14 to 76 years), were included. Murine typhus was more frequent in summer (Figure 1). No case aggregation was observed. The geographic distribution is shown in Figure 2. All patients reported contact with animals (13 with dogs, 6 with horses, 5 with goats, 2 with cats, and 1 with camels).

The main symptoms and signs recorded are shown in Table 1. All patients had a high fever (mean 39.3°C) during a mean of 10 days (range 7 to 20 days). A light maculopapular, nonpurpuric rash, with rather centripetal distribution, was a frequent finding (68.2%). Up to one third of the patients had a dry cough. Hepatomegaly and, less frequently, splenomegaly were detected. Skin lesions suggestive of insect bites were found in 13.6% of the patients.

Four patients had a mild normocytic anemia. For most patients, leukocyte counts were normal, mild leukopenia was detected in two patients, and mild leukocytosis in four patients. Ten case-patients (45%) had thrombocytopenia. In most patients (89.5%), the erythrocyte sedimentation rate was high (11 mm–83 mm), and the activated partial thromboplastin time (aPTT) was prolonged in six patients.

Aminotransferase elevation, usually four times above normal, was found frequently; two patients had normal values. Four patients had alanine aminotransferase values 10 times the normal value. Plasma bilirubin was normal for all patients.

In 36% of the patients, the plasma blood urea nitrogen was elevated; plasma creatinine was above normal in three cases (13%). In 19 cases (87%), alterations were found in the urinalysis. Fifteen patients had proteinuria and microhematuria with or without leukocyturia and granular casts, with a negative nitrite reaction. In two patients, isolated proteinuria occurred, and isolated microhematuria occurred in two other patients. All of these findings resolved quickly.

Eight patients fulfilled both diagnostic criteria (IgM >1:40 plus seroconversion), eight patients had initial IgM elevation, and six seroconverted without IgM increase. Cross-reactivity between R. typhi and other microorganisms was not observed. Fifty percent of the patients had serologic evidence of past infection with C. burnetii (12/22) or R. conorii (3/22) and, in one case, of co-infection with C. burnetii.

Eight cases were not treated because of spontaneous recovery. The remaining patients received doxycycline (100 mg twice a day). Fever disappeared from 1 to 6 days (median 2 days).

Three patients had severe signs and symptoms. Patient 6 was admitted with acute respiratory failure, lung infiltrates, and acute renal failure (plasma creatinine 2.8% mg), microhematuria, and leukocyturia. Intravenous fluids, doxycycline, ciprofloxacin, and methylprednisolone (1 g) were administered, and the patient rapidly improved. Autoantibodies and cryoglobulins were negative. Patient 16 had a dry cough and acute renal failure (plasma creatinine 2.7% mg) and later become disoriented. A cranial contrast computed tomography scan was normal, and cerebrospinal fluid (CSF) showed mononuclear pleocytosis (90 cells/mL), protein 70 mg/dL, and normal glucose. Doxycycline was administered with rapid neurologic improvement. Conjunctivitis and rash appeared but waned shortly after. Finally, patient 21 had a progressive meningeal syndrome, CSF showed mononuclear pleocytosis (19 cells/mL), increased protein (49 mg/dL), and normal glucose level. The patient completely recovered in 48 hours after receiving doxycycline.

Fever of intermediate duration has been defined by others in Spain as fever of 7 to 28 days without localizing signs (i.e., respiratory, digestive, urinary, or neurologic), plus the absence of diagnostic clues after a complete evaluation (6). A few diseases can account for most cases of this type of fever (mainly Q fever, brucellosis, boutonneuse fever, leptospirosis, mononucleosic syndromes, and murine typhus). In our area, autochthonous cases of boutonneuse fever or brucellosis have never been reported. Diagnosis is usually based on serology, which requires time for confirmation. Therefore, in the meantime, identifying clinical data for empirical treatment is important.

In our study, the number of cases per year is 12, higher than that in other areas of Spain (6), Israel (8), or the United States (9,10), with higher rate in summer. Most patients were male. All patients had direct contact with animals as reported by others (9,10); dogs were the most frequently cited animal (9,10).

The clinical features in our study are similar to those reported by others (6,9–13) with respect to those most frequent symptoms (fever, headache, and arthromyalgia) (Table 1). The incidence of rash is similar to that reported by Bernabeu (6) and Whiteford (9) and higher than that in other series. Reports of insect bites were more frequent in our study than studies from other areas (Bernabeu [6] and Silpapojakul [11]), but more insect bites were reported from a Texas study (9).

The laboratory findings in our study are similar to findings in other studies, although its relative frequency is variable (Table 2). The frequency of anemia varies from 1% to 69%, leukopenia from 4% to 40%, and thrombocytopenia from 3% to 60% (6,9,10,11). While 80% of the patients with Q fever in our area have a prolonged aPTT, 27% of the patients with murine typhus displayed this abnormal coagulation test. An elevation of aminotransferases in the range of viral hepatitis was common, but hyperbilirubinemia is exceptional and usually associated with alcoholism, co-infection, or glucose 6-phosphate dehydrogenase deficiency.

Nephrologic alterations had a high frequency in our study. Three patients had acute renal failure, and 87% had some abnormality in the urinalysis, mainly microhematuria. These data are in sharp contrast with the low incidence of urinary alterations found in other studies. Some broad studies (6,9,10) do not report urinary abnormalities in murine typhus, though Dumler et al. (13) reported microhematuria or proteinuria in 28% of their patients. In a study specifically focused on renal involvement in murine typhus, Shaked et al. observed urinary abnormalities in 5 of 27 patients studied (8). To the best of our knowledge, 11 cases of acute renal failure have been related to R. typhi (9,11,14,15).

In general, murine typhus is a mild disease. However, a number of miscellaneous complications have been described. Our severe cases accounted for 13% (one renopulmonary syndrome, one encephalitis, and one meningitis with renal failure).

Conclusions

In summary, in the Canary Islands, incidence of murine typhus seem to be higher, patients more frequently report contact with dogs, the frequency of complicated cases is higher, and the incidence of renal involvement is higher. These data define a clinical picture of murine typhus that is somewhat different for the Canary Islands. These differences could be attributed to age (infantile versus adult series), mode of transmission or infection, or different strains of R. typhi. The diagnostic methodology was indirect, so cross-reaction with other rickettsiae cannot be excluded (11). Moreover, in our area, dogs are frequently parasitized by the flea of cats, a well-known vector for R. felis (3). More studies with direct diagnostic methods are needed to better define these differences. Finally, detecting urinary abnormalities in the setting of fever of intermediate duration, especially if associated with skin rash, thrombocytopenia, or hypertransaminasemia, in our geographic area is strongly suggestive of murine typhus.

Dr. Hernández-Cabrera was an associate professor of infectious diseases and tropical medicine at Faculty of Medicine at University of Las Palmas de Gran Canaria, Spain. His research interests focus on rickettsial diseases and other causes of fever of intermediate duration.

References

  1. Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 1997;10:694–719.
  2. Azad AF. Epidemiology of murine typhus. Annu Rev Entomol 1990;35:553–69.
  3. Márquez FJ, Muniain MA, Pérez JM, Pachón J. Presence of Rickettsia felis in the cat flea from southwestern Europe. Emerg Infect Dis 2002;8:89–91.
  4. Ruiz Beltrán R , Herrero-Herrero JI, Martín-Sánchez AM, Martín-González JA. Prevalence of antibodies to Rickettsia conorii, Coxiella burnetii and Ricketssia typhi in Salamanca Province (Spain). Serosurvey in the human population. Eur J Epidemiol 1990:6:293–9.
  5. Lledo L, Gegundez MI, Saz JV, Beltran M. Prevalence of antibodies to Rickettsia typhi in an area of the center of Spain. Eur J Epidemiol 2001;17:927–8.
  6. Bernabeu-Wittel M, Pachon J, Alarcón A, López-Cortés LF, Viciana P, Jiménez-Mejías ME, et al. Murine typhus as a common cause of fever of intermediate duration. A 17-year study in the south of Spain. Arch Intern Med 1999;159:872–6.
  7. Padilla ML, Martinez A, Abella L, Marañés I, Míguelez M, Laynez P, et al. In: Abstracts of the VII Congreso de la Sociedad Canaria de Medicina Interna Adeje (Spain) 22–24 June 2000; Abstract 12.
  8. Whiteford SF, Taylor JP, Dumler JS. Clinical, laboratory, and epidemiologic features of murine typhus in 97 Texas children. Arch Pediatr Adolesc Med 2001;155:396–400.
  9. Fergie JE, Purcell K, Wanat D. Murine typhus in South Texas children. Pediatr Infect Dis J 2000;19:535–8.
  10. Silpapojakul K, Chayakul P, Krisanapan S. Murine typhus in Thailand: clinical features, diagnosis and treatment. QJM 1993;86:43–7.
  11. Gikas A, Doukakis S, Pediaditis J, Kastanakis S, Psaroulaki A, Tselentis Y. Murine typhus in Greece: epidemiological, clinical and therapeutic data from 83 cases. Trans R Soc Trop Med Hyg 2002;96:250–3.
  12. Dumler JS, Taylor JP, Walker DH. Clinical and laboratory features of murine thypus in south Texas, 1980 through 1987. JAMA 1991;266:1365–70.
  13. Rosenthal T, Michaeli D. Murine typhus and spotted fever in Israel in the seventies. Infection 1977;5:82–4.
  14. Whelton A, Douglas JV, Elisberg BI. Acute renal failure complicating rickettsial infection in glucose-6-phosphate dehydrogenase deficient individuals. Ann Intern Med 1968;69:323–8.

 

Table 1. Clinical findingsa

Clinical findings

Researcher and location of study


Dumler, TX
1991

Silpapojakul, Thailand
1992

Bernabeu, Seville
1999

Fergie, TX
2000

Whiteford, TX
2001

Gikas, Crete
2002

Canary Islands
2003


n

80

137

104

30

97

83

22

Fever

98

100

100

100

100

100

100

Headache

75

41

71

77

76

88

90

Rash

54

20

62

80

63

80

-

Arthromyalgia

46

44

77

57

40

45

45

Hepatomegaly

-

24

29

-

-

22

38

Cough

35

-

25

40

15

28

28

Diarrhea

26

5

5

40

33

11

18

Splenomegaly

-

5

24

-

-

23

14

Bite

39

0

3

3,3

34

-

13

Nausea/vomiting

48

3

23

43

45

18

13

Abdominal pain

23

10

-

60

27

11

13

Confusion

8

2

4

7

8

10

13


aData are expressed as a percentage; TX, Texas.

 

Table 2. Comparative laboratory findings in patients with murine typhusa

Laboratory test results

Researcher and location of study


Dumler, TX

Silpapojakul, Thailand

Bernabeu, Sevilla

Fergie, TX

Whiteford, TX

Gikas, Crete

Canary Islands


Anemia

75

-

1

57

69

25

18

Leukopenia

28

4

18

40

37

7

9

Leukocytosis

29

-

20

3

1

0

18

Neutrophilia

-

-

-

63

77

-

36

Thrombocytopenia

48

3

19

60

43

51

45

ESR elevated

-

-

59

75

81

-

89

Increased ratio prothrombin time

30

-

-

-

-

-

23

Increased ratio aPTT

-

-

-

-

-

-

27

Plasma BUN increased

27

-

-

0

3

-

36

Plasma creatinine increased

21

-

-

0

0

-

14

Hyponatremia

60

-

-

66

58

37

18

Plasma creatine kinase increased

21

-

-

-

-

42

10

Plasma LDH increased

87

-

-

-

100

82

81

Plasma AST increased

90

-

67

67

82

86

77

Plasma ALT increased

73

-

67

67

38

64

99

Plasma alkaline phosphatase increased

60

-

25

-

-

15

30

Plasma GGT increased

-

-

-

-

-

-

57.2

Hypoalbuminemia

89

-

-

46

87

82

54.5

Hypergammaglobulinemia

-

-

-

-

-

-

75.0


aData are expressed as a percentage. TX, Texas; ESR, erythrocyte sedimentation rate; aPTT, activated partial thromboplastin time; BUN, blood urea nitrogen; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma glutamic transferase.

1Drs. Hernández-Cabrera and Angel-Moreno contributed equally to the article.

   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

José Luis Pérez-Arellano, Departamento de Ciencias Médicas y Quirúrgicas, Universidad de Las Palmas de Gran Canaria, 35080, Canary Islands, Spain; fax: 928451413; email: jlperez@dcmq.ulpgc.es

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

Email this article

Your email:

Your friend's email:

Message (optional):

 

 

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted March 16, 2004
This page last reviewed June 24, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention